Catherine Coste

Catherine Coste

Director/Board Member at RENALYTIX PLC

Net worth: 491 520 $ as of 30/07/2026

60 year
Health Technology
Commercial Services
Consumer Services

Profile

Catherine Havlik Coste is currently an Independent Non-Executive Director at Renalytix Plc since 2023 and an Independent Director at BioLife Solutions, Inc. starting in 2025.
Formerly, Ms. Coste was an Independent Director at Biomerica, Inc. from 2020 to 2025, an Independent Director at Minerva Surgical, Inc. from 2021 to 2025, and a Senior Partner at Deloitte & Touche LLP from 1988 to 2020.
Education includes undergraduate studies at California State University-East Bay.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/02/2026 13,871 ( 0.03% ) 433 885 $ 30/07/2026
01/09/2026 1,616,231 ( 0.37% ) 57 635 $ 30/07/2026

Catherine Coste active positions

CompaniesPositionStart
RENALYTIX PLC Director/Board Member 29/06/2023
BIOLIFE SOLUTIONS, INC. Director/Board Member 17/03/2025

Former positions of Catherine Coste

CompaniesPositionEnd
BIOMERICA, INC. Director/Board Member 03/06/2025
MINERVA SURGICAL, INC. Director/Board Member 30/04/2025
Corporate Officer/Principal 31/08/2020
See the detail of Catherine Coste's experience

Training of Catherine Coste

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Catherine Coste